“…Electrochemiluminescence (ECL) as an electrochemically triggered luminescence technique has received continuously growing scientific interest owing to its merits of high sensitivity, simplicity of operation, and excellent spatiotemporal control on light emission . To date, the ECL technique has been researched in depth with wide application extension in real-time health monitoring, point-of-care diagnosis, and sandwich-type immunoassays. , Besides the tris(2,2′-bipyridine)ruthenium(II) [Ru(bpy) 3 2+ ]-centered sensing paradigm accompanied by tri- n -propylamine (TPrA), various interesting ECL-active iridium(III) complexes recently arose to gain significant momentum triggered by the need for diverse emitters with high efficiency. , Iridium(III) complexes have high quantum efficiencies, long luminescence lifetimes, tunable emission wavelengths, and high thermal and electrochemical stabilities. , They have been recently applied for sensitive analysis of nucleic acids and aromatic molecules, as well as biomarkers by constructing ECL devices that can rapidly quantify the contents of the target. − As previously reported, the cyclometalated iridium(III) complex of bis(2-phenylpyridinato)acetylacetonate [Ir(ppy) 2 (acac)] can exhibit comparable ECL efficiency with the elegant Ru(bpy) 3 2+ /TPrA standard . Nevertheless, the water-insolubility of Ir(ppy) 2 (acac) restricted its application in biosensing.…”